Sofosbuvir Completed Phase 2 Trials for chronic, recurrent Hepatitis C Virus / Post Liver Transplant Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01687270Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant